miR-195 Targets HDGF to inhibit proliferation and invasion of NSCLC cells

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 8861-8866

  Guo, Haizhou ^a   Li, Weihao ^a   Zheng, Tianliang ^a   Liu, Zhangsuo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

HDGF; Invasion; Migration; miR 195; NSCLC; Proliferation

Indexed keywords

HEPATOMA DERIVED GROWTH FACTOR; KI 67 ANTIGEN; MICRORNA; MICRORNA 195; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HEPATOMA-DERIVED GROWTH FACTOR; LUCIFERASE; MIRN195 MICRORNA, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; METASTASIS; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; 3' UNTRANSLATED REGION; CELL MOTION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84919866014     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2153-0     Document Type: Article

References (24)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: Cancer J Clin. 2011;61:212–36.
2. van Klaveren RJ. Lung cancer screening. Eur J Cancer. 2011;47 Suppl 3:S147–55.
3. Bouyssou JM, Manier S, Huynh D, Issa S, Roccaro AM, Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta. 1845;2014:255–65.
4. Zagryazhskaya A, Zhivotovsky B: Mirnas in lung cancer: A link to aging. Ageing research reviews 2014
5. Zhang W, Bai W, Zhang W: MiR-21 suppresses the anticancer activities of curcumin by targeting pten gene in human non-small cell lung cancer a549 cells. Clinical and translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2013
6. Wan L, Zhang L, Fan K, Wang J: MiR-27b targets limk1 to inhibit growth and invasion of NSCLC cells. Molecular and cellular biochemistry 2014
7. Zhan M, Qu Q, Wang G, Zhou H. Let-7c sensitizes acquired cisplatin-resistant a549 cells by targeting abcc2 and bcl-xl. Die Pharmazie. 2013;68:955–61.
8. Molina-Pinelo S, Gutierrez G, Pastor MD, Hergueta M, Moreno-Bueno G, Garcia-Carbonero R, et al. Microrna-dependent regulation of transcription in non-small cell lung cancer. PLoS One. 2014;9:e90524.
9. Zhang N, Wei X, Xu L. Mir-150 promotes the proliferation of lung cancer cells by targeting p53. FEBS Lett. 2013;587:2346–51.
10. Ke Y, Zhao W, Xiong J, Cao R. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. FEBS Lett. 2013;587:3153–7.
11. Lei L, Huang Y, Gong W. Inhibition of mir-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting reck. Mol Cell Biochem. 2014;387:171–6.
12. Luo Q, Wei C, Li X, Li J, Chen L, Huang Y, et al. Microrna-195-5p is a potential diagnostic and therapeutic target for breast cancer. Oncol Rep. 2014;31:1096–102.
13. Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, et al. The tumor-suppressive mir-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS One. 2013;8:e60155.
14. Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, et al. Microrna-195 inhibits the proliferation of human glioma cells by directly targeting cyclin d1 and cyclin e1. PLoS One. 2013;8:e54932.
15. Mao JH, Zhou RP, Peng AF, Liu ZL, Huang SH, Long XH, et al. Microrna-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting fasn. Oncol Lett. 2012;4:1125–9.
16. Qu J, Zhao L, Zhang P, Wang J, Xu N, Mi W, Jiang X, Zhang C, Qu J: Microrna-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of bcl2l2 mRNA. Journal of cellular physiology 2013
17. Deng H, Guo Y, Song H, Xiao B, Sun W, Liu Z, et al. Microrna-195 and microrna-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene. 2013;518:351–9.
18. Yongchun Z, Linwei T, Xicai W, Lianhua Y, Guangqiang Z, Ming Y, Guanjian L, Yujie L, Yunchao H: Microrna-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Cancer letters 2014
19. Huang JS, Chao CC, Su TL, Yeh SH, Chen DS, Chen CT, et al. Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2004;315:950–8.
20. Mori M, Morishita H, Nakamura H, Matsuoka H, Yoshida K, Kishima Y, et al. Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Am J Respir Cell Mol Biol. 2004;30:459–69.
21. Chen B, Huang T, Jiang J, Lv L, Li H, Xia S. Mir-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF. Mol Cell Biochem. 2014;388:211–8.
22. Zhou Y, Zhou N, Fang W, Huo J. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Diagn Pathol. 2010;5:58.
23. Uyama H, Tomita Y, Nakamura H, Nakamori S, Zhang B, Hoshida Y, et al. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2006;12:6043–8.
24. Zhao WY, Wang Y, An ZJ, Shi CG, Zhu GA, Wang B, et al. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem Biophys Res Commun. 2013;435:466–71.